New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Burning Rock Biotech Limited
BNR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

31M

Medical - Diagnostics & Research

Next Earning date - 05 Dec 2024

31M

Medical - Diagnostics & Research

Next Earning date - 05 Dec 2024

3.04USD
Shape0.14 ( 4.64%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-35%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated October 19, 2024
1W -2.56 % 1M -5.57 % 3M -56.92 % 1Y -70.10 %

Key Metrics

Shape
  • Market Cap

    31.19M


  • Shares Outstanding

    10.24M


  • Share in Float

    10.22M


  • Dividende

    0


  • Earning Date

    05 Dec 2024


  • Price Target

    3.045


  • Average Volume

    25635


  • Beta

    0.131


  • Range

    2.62-11.4


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.brbiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.43x

P/S Ratio

0.33x

P/B Ratio

0.2

Debt/Equity

-111.2%

Net Margin

$-7.8

EPS

How BNR compares to sector?

P/E Ratio

Relative Strength

Shape

BNR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$938M

Shape592%

2025-Revenue

$26.86

Shape-155%

2025-EPS

$801M

Shape-618%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-3.10
vs -2.50

Q4.22

arrow
arrow

N/A

-3.10
vs -3.80

Q1.23

arrow
arrow

N/A

-2.60
vs -3.90

Q2.23

arrow
arrow

N/A

-1.80
vs -3.70

Q3.23

arrow
arrow

N/A

-2.30
vs -3.10

Q4.23

arrow
arrow

N/A

-2.20
vs -3.10

Q1.24

arrow
arrow

N/A

-0.16
vs -2.60

Q2.24

arrow
arrow

N/A

-0.14
vs -1.80

Q3.24

arrow
arrow

N/A

-9.89
vs -2.30

Q4.24

arrow
arrow

N/A

-10.22
vs -2.20

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+22%

154.6M  vs 126.6M

Q4.22

arrow
arrow

-3%

142.2M  vs 147.3M

Q1.23

arrow
arrow

+5%

142.5M  vs 135.5M

Q2.23

arrow
arrow

+12%

146.3M  vs 130.8M

Q3.23

arrow
arrow

-17%

127.6M  vs 154.6M

Q4.23

arrow
arrow

-15%

121.1M  vs 142.2M

Q1.24

arrow
arrow

-12%

125.6M  vs 142.5M

Q2.24

arrow
arrow

-7%

135.5M  vs 146.3M

Q3.24

arrow
arrow

+9%

138.6M  vs 127.6M

Q4.24

arrow
arrow

+17%

141.7M  vs 121.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-17%

-0.17
vs -0.18

Q4.22

arrow
arrow

-19%

-0.19
vs -0.17

Q1.23

arrow
arrow

-18%

-0.18
vs -0.19

Q2.23

arrow
arrow

-14%

-0.14
vs -0.18

Q3.23

arrow
arrow

-20%

-0.20
vs -0.14

Q4.23

arrow
arrow

-21%

-0.21
vs -0.20

Q1.24

arrow
arrow

-17%

-0.17
vs -0.21

Q2.24

arrow
arrow

-16%

-0.16
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

48

48
vs 48

NA

Q4.22

arrow
arrow

40

40
vs 48

-17%

Q1.23

arrow
arrow

32

32
vs 40

-20%

Q2.23

arrow
arrow

31

31
vs 32

-3%

Q3.23

arrow
arrow

27

27
vs 31

-13%

Q4.23

arrow
arrow

20

20
vs 27

-26%

Q1.24

arrow
arrow

20

20
vs 20

NA

Q2.24

arrow
arrow

2

2
vs 20

-90%

Earnings Growth

Latest News